Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Neuromuscular BlockEsophageal CancerSurgery

Interventions

DRUG

Rocuronium

Rocuronium given continuously to reach deep neuromuscular block

Trial Locations (1)

Academic Medical Center, Amsterdam

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02320734 - Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy | Biotech Hunter | Biotech Hunter